Nab-paclitaxel

SEP 4, 2026 · PHASE 3 TRIAL

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

ClinicalTrials.gov

This is an actively recruiting Phase 3 trial with no results posted; the registry record describes planned design and enrollment only, with no outcome data available for assessment.

AUG 20, 2026 · PHASE 3 TRIAL

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ClinicalTrials.gov

This is a Phase 3 trial registration with no reported results; the study is actively recruiting and outcome data are not yet available.

AUG 7, 2026 · PHASE 3 TRIAL

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results reported; it describes a planned comparison but cannot yet support clinical evidence or practice guidance.